XML 38 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Consolidated net loss $ (42,262) $ (22,886)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 42,853 41,675
Assets impairment charges 2,025 0
Intangible asset impairment charge 34,900 0
Amortization of intangibles, deferred financing costs and bond premium 7,039 8,227
Non-cash write off of deferred financing cost   1,853
Provision for doubtful accounts 85 1,033
Provision for inventory obsolescence 38 95
Non-cash share-based compensation expense - net 538 195
Gain on sales and disposals of equipment (1,234) (801)
Deferred income taxes (13,629) 676
Changes in operating assets and liabilities:    
Accounts receivable 810 (321)
Inventories (476) (921)
Other operating assets (1,394) (792)
Accounts payable 674 (1,465)
Other operating liabilities 2,234 3,639
Net cash provided by operating activities 32,201 30,207
Cash flows from investing activities:    
Medical equipment purchases (34,766) (28,478)
Property and office equipment purchases (2,560) (4,178)
Proceeds from disposition of property and equipment 5,970 1,929
Purchases of noncontrolling interests (34)  
Holdback payment related to acquisition   (1,655)
Net cash used in investing activities (31,390) (32,382)
Cash flows from financing activities:    
Proceeds under senior secured credit facility 76,129 43,300
Payments under senior secured credit facility (69,129) (36,800)
Payments of principal under capital lease obligations (3,429) (4,150)
Payments of floating rate notes   (230,000)
Proceeds from issuance of bonds   234,025
Accrued interest received from bondholders   8,620
Accrued interest paid to bondholders   (8,620)
Distributions to noncontrolling interests (295) (379)
Dividend and equity distribution payments (73)  
Payment of deferred financing costs   (4,102)
Change in book overdrafts (4,014) 281
Net cash (used in) provided by financing activities (811) 2,175
Supplemental cash flow information:    
Interest paid 26,228 21,620
Income taxes paid 309 332
Non-cash activities:    
Medical equipment purchases included in accounts payable (at end of period) 4,598 8,008
Capital lease additions $ 768 $ 4,438